LINANEXT 5 contains Linagliptin which is an oral anti-diabetic agent. It is used to treat type 2 diabetes mellitus in adults when treatment with first line oral anti-diabetic medicine (such as metformin) or diet and exercise does not give adequate response. It is generally used in combination with other anti-diabetic medicines (such as metformin, glimepiride, glipizide, empagliflozin, or insulin) for better results. Type 2 diabetes is a chronic medical condition in which the body does not make enough insulin, or the produced insulin does not work well. Symptoms includes excessive urination, excessive thirst, hunger, fatigue, and blurred vision.
Linagliptin is a DPP-4 inhibitor. It helps pancreas to secrete more insulin (a hormone that digests glucose/sugar) by inhibiting an enzyme called Dipeptidyl peptidase 4, which ultimately leads to decrease in blood glucose level. Along with the treatment, follow regular exercise and diet plan as advised by your doctor to achieve better results.
LINANEXT 5 is strictly not recommended for use in children and adolescents under 18 years of age. Your doctor will monitor your blood sugar levels through periodic blood/urine tests. Before taking LINANEXT 5 inform your doctor if you have or ever had kidney disease, heart disease, or pancreas problems. LINANEXT 5 should be used with caution in pregnant and breast-feeding women. The most common side effects of LINANEXT 5 are fast heartbeat, anxiety, increased sweating, and tiredness.